ATIVA’s rapid low-cost COVID-19 test may provide earlier detection and a safer community
The greatest challenge we face is the spread of infection before symptoms appear. We all want to protect our loved ones, so how do we know if we are infected? Physical symptoms (fever, cough) appear too late to stop the spread, antibodies appear even later. The nasal swab PCR test suffers from sampling errors, slow time to results, and is quite expensive. Early detection of infected people is the key to protecting our most vulnerable people in assisted-living centers, cancer wards, our valued frontline workers (EMTs, nurses) and our essential workers in critical infrastructure or food processing jobs.